Inhibitory effect of bone morphogenetic protein-7 on hepatic fibrosis in rats

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 5, 2013, Pages 897-903

  Wang, Sheng Lan ^a   Yang, Chang Qing ^a   Qi, Xiao Long ^a   Yuan, Min ^a   Chang, Yi Zhong ^a   Yang, Li ^a   Gao, Heng Jun ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bone morphogenetic protein 7; Extracellular matrix; Hepatic fibrosis; Hepatic stellate cell; Transforming growth factor beta 1

Indexed keywords

BMP7 PROTEIN, RAT; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; BIOSYNTHESIS; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; METABOLISM; RAT; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 7; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84882975298     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wang JY, Guo JS and Yang CQ. Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis. World J Gastroenterol 2002; 8: 901-907.
2. Gressner OA, Rizk MS, Kovalenko E, Weiskirchen R and Gressner AM. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol 2008; 23: 1024-1035.
3. Ueno T, Nakamura T, Torimura T and Sata M. Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol 2006; 39: 16-21.
4. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER and Brenner DA. The role of tgfbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999; 30: 77-87.
5. Zeisberg M, Shah AA and Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 2005; 280: 8094-8100.
6. Yang L, Yang CQ, Yuan M, Wang SL, Chang YZ, Xu LJ, Zhang ZJ. [Effects of bone morphogenic proteins-7 on production of collagen from hepatocytes and hepatic stellate cells during liver fibrosis]. Zhonghua Yi Xue Za Zhi 2009; 89: 419-422.
7. Adachi T, Takanaga H, Kunimoto M and Asou H. Influence of lif and bmp-2 on differentiation and development of glial cells in primary cultures of embryonic rat cerebral hemisphere. J Neurosci Res 2005; 79: 608-615.
8. Yamaguchi A. [Application of bmp to bone repair]. Clin Calcium 2007; 17: 263-269.
9. Zou H, Choe KM, Lu Y, Massague J and Niswander L. Bmp signaling and vertebrate limb development. Cold Spring Harb Symp Quant Biol 1997; 62: 269-272.
10. Massague J and Weis-Garcia F. Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals. Cancer Surv 1996; 27: 41-64.
11. Yamashita H, Ten Dijke P, Heldin CH and Miyazono K. Bone morphogenetic protein receptors. Bone 1996; 19: 569-574.
12. Reddi AH. Bone morphogenetic proteins: From basic science to clinical applications. J Bone Joint Surg Am 2001; 83-A Suppl 1: S1-6.
13. Forino M, Torregrossa R, Ceol M, Murer L, Della Vella M, Del Prete D, D'Angelo A, Anglani F. TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol 2006; 87: 197-208.
14. Meindl-Beinker NM and Dooley S. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis. J Gastroenterol Hepatol 2008; 23 Suppl 1: S122-127.
15. Hui AY and Friedman SL. Molecular basis of hepatic fibrosis. Expert Rev Mol Med 2003; 5: 1-23.
16. Wang S and Hirschberg R. BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 2003; 284: F1006-1013.
17. Izumi N, Mizuguchi S, Inagaki Y, Saika S, Kawada N, Nakajima Y, Inoue K, Suehiro S, Friedman SL, Ikeda K. BMP-7 opposes TGF-beta1- mediated collagen induction in mouse pulmonary myofibroblasts through id2. Am J Physiol Lung Cell Mol Physiol 2006; 290: L120-126.
18. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968.
19. Wang SE, Wu FY, Shin I, Qu S and Arteaga CL. Transforming growth factor ß (TGFß)-smad target gene protein tyrosine phosphatase receptor type kappa is required for TGFß function. Mol Cell Biol 2005; 25: 4703-4715.
20. Saika S, Ikeda K, Yamanaka O, Flanders KC, Ohnishi Y, Nakajima Y, Muragaki Y, Ooshima A. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 2006; 290: C282- 289.
21. Xu Y, Wan J, Jiang D and Wu X. BMP-7 counteracts TGF-beta1-induced epithelial-tomesenchymal transition in human renal proximal tubular epithelial cells. J Nephrol 2009; 22: 403-410.
22. Gould SE, Day M, Jones SS and Dorai H. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 2002; 61: 51-60.
23. Lee MJ, Yang CW, Jin DC, Chang YS, Bang BK and Kim YS. Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 betainduced monocyte chemoattractant protein-1 expression in human mesangial cells: Role for jnk/ap-1 pathway. J Immunol 2003; 170: 2557-2563.
24. Wang S and Hirschberg R. Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem 2004; 279: 23200-23206.
25. Benchabane H and Wrana JL. Gata- and smad1-dependent enhancers in the smad7 gene differentially interpret bone morphogenetic protein concentrations. Mol Cell Biol 2003; 23: 6646-6661.
26. Harada N, Hatano E, Koizumi N, Nitta T, Yoshida M, Yamamoto N, Brenner DA, Yamaoka Y. Akt activation protects rat liver from ischemia/ reperfusion injury. J Surg Res 2004; 121: 159- 170.
27. Carini R, Grazia De Cesaris M, Splendore R, Baldanzi G, Nitti MP, Alchera E, Filigheddu N, Domenicotti C, Pronzato MA, Graziani A, Albano E. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 2004; 127: 914-923.
28. Valcourt U, Kowanetz M, Niimi H, Heldin CH and Moustakas A. TGF-beta and the smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005; 16: 1987- 2002.
29. Tacke F, Gäbele E, Bataille F, Schwabe RF, Hellerbrand C, Klebl F, Straub RH, Luedde T, Manns MP, Trautwein C, Brenner DA, Schölmerich J, Schnabl B. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig Dis Sci 2007; 52: 3404-3415.
30. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA and Brenner DA. The role of smad3 in mediating mouse hepatic stellate cell activation. Hepatology 2001; 34: 89-100.